Yano Research Institute Releases Report on Japanese Pharmaceutical Market.

Tokyo, Japan, Jan 26, 2006 - (JCN) - Japanese market researcher Yano Research Institute (YRI) announced on January 25 that it has published a report on the Japanese pharmaceutical market.

Entitled "Pharmaceutical Market 2006: A 10-Year Market Forecast," the report forecasts that the pharmaceutical industry will continue to face a tough situation as medical treatment fees paid to hospitals and clinics will be reduced and the NHI drug price will be revised through upcoming medical service reforms.

The report forecasts the Japanese ethical drug market (production output of ethical drugs) from two perspectives. Under the first scenario, which assumes a severe affect of the medical service reforms on demand for drugs, the market is estimated to have reached 6,952.6 billion yen ($60.5 bil) in 2005, and to reach 6,989.2 billion yen ($60.8 bil) in 2009 and 7,263.7 billion yen ($63.2 bil) in 2013.

Under the second scenario, which assumes that a damage of the reforms will be avoided as demand for drugs will steadily grow and corporate efforts will be made, the market is estimated to have reached 7,198.2 billion yen ($62.6 bil) in 2005, and to reach 7,614.2 billion yen ($66.2 bil) in 2009 and 8,149.3 yen ($70.9 bil) in 2013.

In terms of segments with growth potential, the report cites digestive drugs, metabolic drugs, anti-tumor agents, central nervous system drugs, genitourinary drugs, hormone agents and diagnostic products.

The 231-page report (in Japanese) is available for 126,000 yen ($1,100).

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.